Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Leukemia|August 4, 2022
Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemiaTiina Kelkka, Mikko Tyster, Sofie Lundgren, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
Scientific Reports|February 24, 2017
Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibodyYoshimasa Hamano, Hiroshi Kida, Shoichi Ihara, et al.
International Journal of Cancer|November 26, 2009
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancerSacha Gnjatic, Yanran Cao, Uta Reichelt, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Nature Communications|December 15, 2023
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin stateMuran Xiao, Shinji Kondo, Masaki Nomura, et al.
Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature Communications|November 6, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic VulnerabilitiesShigenari Nukaga, Kouya Shiraishi, Kenta Hamabe, et al.
The New England Journal of Medicine|January 6, 2021
Vaginal Transmission of Cancer from Mothers with Cervical Cancer to InfantsAyumu Arakawa, Hitoshi Ichikawa, Takashi Kubo, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Leukemia|August 4, 2022
Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemiaTiina Kelkka, Mikko Tyster, Sofie Lundgren, et al.
Science Immunology|November 12, 2021
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escapeYoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, et al.
Scientific Reports|February 24, 2017
Classification of idiopathic interstitial pneumonias using anti-myxovirus resistance-protein 1 autoantibodyYoshimasa Hamano, Hiroshi Kida, Shoichi Ihara, et al.
International Journal of Cancer|November 26, 2009
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancerSacha Gnjatic, Yanran Cao, Uta Reichelt, et al.
Nature Cancer|February 19, 2025
Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802)Hideaki Bando, Shogo Kumagai, Daisuke Kotani, et al.
Nature Communications|December 15, 2023
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin stateMuran Xiao, Shinji Kondo, Masaki Nomura, et al.
Nature Immunology|September 2, 2020
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapiesShogo Kumagai, Yosuke Togashi, Takahiro Kamada, et al.
Nature Communications|November 6, 2025
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic VulnerabilitiesShigenari Nukaga, Kouya Shiraishi, Kenta Hamabe, et al.
The New England Journal of Medicine|January 6, 2021
Vaginal Transmission of Cancer from Mothers with Cervical Cancer to InfantsAyumu Arakawa, Hitoshi Ichikawa, Takashi Kubo, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Pageof 20